Not Yet RecruitingNot Applicable

Study to Evaluate the Clinical Utility of Radiation Exposure Reduction: Multi-site Rampart Guardian Peripheral Trial

United States75 participantsStarted 2026-05-15

Plain-language summary

Study to Evaluate the Clinical Utility of Radiation Exposure Reduction (SECURE): Multi-site Rampart Guardian Peripheral Trial

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Member of the interventional care team * Elective peripheral procedure * The access site is the femoral artery * The treatment area is at or distal to the iliac artery Exclusion Criteria: * Individuals who are not yet adults, pregnant women, or prisoners. * Urgent and emergent cases

What they're measuring

The difference in radiation exposure to the care team using a Raysafe i3 dosimeter badge.

Timeframe: Intraprocedural

Trial details

NCT IDNCT07467720

SponsorBaylor Research Institute

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2027-05-15

Contact for this trial

Bonnie Ostergren

469-814-4181 bonnie.ostergren@bswhealth.org

View on ClinicalTrials.gov More Radiation Protection trials